Status:

COMPLETED

Interferon-alpha2a Versus Cyclosporin A for Severe Ocular Behcet's Disease (INCYTOB)

Lead Sponsor:

University Hospital Tuebingen

Conditions:

Behcet's Disease

Panuveitis

Eligibility:

All Genders

18-75 years

Phase:

PHASE3

Brief Summary

The purpose of this study is to investigate if interferon-alpha2a is superior to the standard treatment with cyclosporin A for the treatment of severe ocular manifestations of Behcet's disease.

Detailed Description

Behcet's disease is a multisystem vasculitis often involving ocular (retinal) blood vessels (in 70% of all cases). This form of uveitis or retinal vasculitis still leads to blindness in 25 to 50% of t...

Eligibility Criteria

Inclusion

  • Behçet's disease fulfilling the International Study Group Criteria with active pan- or posterior uveitis (according to the posterior uveitis scoring system) or retinal vasculitis and active disease according to the Behcet's Disease activity scoring system.

Exclusion

  • Previous treatment with interferon-α or cyclosporin A
  • Pregnancy, breast feeding women, malignancy
  • Renal impairment (creatinine \> 1.5 mg/dl)
  • Uncontrolled hypertension or diabetes
  • Depression or other psychic disorders(also history of depression)
  • History of acute or chronic inflammatory joint or autoimmune disease
  • Organ or bone marrow transplant recipient, cardiac failure \> NYHAIII
  • Acute liver disease with SGPT 2x above normal
  • White blood cell count \< 3500/mm3
  • Platelet count \< 100000/mm3
  • Hgb \< 8.5g/dl
  • Body weight \<45 kg
  • Alcohol abuse or drug abuse
  • Mental impairment
  • Uncooperative attitude

Key Trial Info

Start Date :

November 1 2004

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 2014

Estimated Enrollment :

37 Patients enrolled

Trial Details

Trial ID

NCT00167583

Start Date

November 1 2004

End Date

December 1 2014

Last Update

May 17 2018

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Department of Internal Medicine II and Department of Ophthalmology

Tübingen, Germany, D-72076